Edition:
India

People: Quest Diagnostics Inc (DGX.N)

DGX.N on New York Stock Exchange

101.52USD
11:05pm IST
Change (% chg)

$-0.76 (-0.74%)
Prev Close
$102.28
Open
$102.20
Day's High
$102.24
Day's Low
$100.13
Volume
172,079
Avg. Vol
242,593
52-wk High
$107.95
52-wk Low
$78.97

Davis, James 

Mr. James E. Davis is Executive Vice President, General Diagnostics of the Company. In January 2017, Mr. Davis became Executive Vice President, General Diagnostics; previously he was Senior Vice President and Group Executive - Regional Businesses. In January 2015, he assumed responsibility for the general management of the Company's regional Diagnostic Information Services business. Mr. Davis was responsible for our products business from February 2014 until 2016. From February 2014 to January 2015, he was responsible for operations for the Company's Diagnostic Information Services business. He joined Quest Diagnostics in April 2013 as Senior Vice President, Diagnostics Solutions, with responsibility for the healthcare information technology, risk assessment, clinical trials, diagnostic products and employer solutions businesses. Prior to joining Quest Diagnostics, from March 2012 to April 2013, Mr. Davis served as Lead Director, and then as Chief Executive Officer, of InSightec, Inc., a medical device company that designs and develops ultrasound ablation devices that are guided by magnetic resonance imaging systems. Previously, Mr. Davis held a number of senior positions in General Electric’s healthcare business, including from 2007 to 2012 as Vice President and General Manager of GE Healthcare’s magnetic resonance imaging business. Prior to joining GE Healthcare, Mr. Davis held leadership positions in GE’s aviation business and led the development of strategic and operational improvement initiatives for clients of McKinsey & Company, Inc.

Basic Compensation

Total Annual Compensation, USD 815,616
Restricted Stock Award, USD 1,320,100
Long-Term Incentive Plans, USD --
All Other, USD 930,905
Fiscal Year Total, USD 3,066,620

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 63,880 2,971,050.00